The American Heart Association reports that improved prevention efforts as well as improvements in hospital care appear to have contributed to the decline in severity.
FDA has issued white papers detailing sterility testing essentials for medical device makers.
Because hand-held X-rays require operators and patients to be closer to the devices, manufacturers must take extra precautions, FDA says.
Research conducted by Challenger, Gray & Christmas, Inc. shows that job cuts in health care rank in "the middle of the pack" among industries but that health care had the highest turnover among CEOs in 2008.
Johns Hopkins researchers have invented dust-particle-size devices that can be used to grab and remove living cells from hard-to-reach places without the need for electrical wires, tubes or batteries.
FDA has granted expedited review status to the company, which has developed the first non-drug therapy for asthma, called bronchial thermoplasty.
The device extracts and makes a dose of a patient's own adipose tissue-derived adult stem and regenerative cells, which can be used for a variety of medical indications.
Abbott Laboratories said it would acquire Advanced Medical Optics Inc. for $1.36 billion, boosting Abbott's already formidable presence in the eye care business.
UCLA scientists can now see brain aging before symptoms appear using both PET scans and information on patients' Alzheimer's risk.
New York-Presbyterian / Columbia's Dr. Martin Leon and Dr. Craig Smith--who performed a bypass on President Clinton--are testing a new way of inserting a heart valve using a catheter and new fixation method.
JAMA study provides an early assessment of drug therapy versus the use of a medical device.
The acquisition capitalizes on Labcoat's drug-eluting stent technology.
MRI of the wrist at 3T provides a road map for patients with torn ligaments who need surgery and in many cases, can rule out surgery for those patients who don't need it, according to a recent study.
Johnson & Johnson said it has completed its tender offer for shares of Omrix Biopharmaceuticals Inc., a New York-based maker of surgical sealants with production in Israel.
An experimental polymer, made by Nicast Ltd. of Israel, is being tested on dogs with corneal disease. The polymer is formed into fibers that can be used in medical devices that release medication. Human applications may follow.
Back pain affects more than 80 percent of people and costs more than $100 billion annually in the U.S. But is the surgery cost effective?
MIT researchers have developed a drug-delivery system that may be able to release up to three or four drugs in a controlled fashion.
Researchers at Memorial Sloan-Kettering Cancer Center have developed one of the first nanoparticle probes that may be adapted for tumor targeting and treatment. The next generation of nanoparticles may provide better contrast agents for PET imaging.
University of California scientists have found that isothiocyanates, substances found in broccoli, cauliflower and cabbage, prevent breast cancer.
New Year's celebrations will be postponed by one second, says the National Institute of Standards and Technology. The adjustment will be made just before 7 PM, Eastern Time.
Von Eschenbach was appointed by President Bush in 2005.
One extra hour of sleep per night appears to slash the risk of coronary artery calcification, the University of Chicago Medical Center reports. And the benefits appear to be greater for women.
Renowned radiation oncologist Howard Sandler, M.D., has been named chair of Radiation Oncology at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.
A technique developed by Toronto General Hospital and a company called Vitrolife, lets surgeons repair injured donor lungs so they are suitable for transplantation.
Decades-long AAA rating may be in jeopardy.
Jeffrey Immelt told analysts at the company's annual outlook meeting that GE expects to outperform the S&P next year, regardless of the "toughest environment we have ever seen."
Colonoscopy significantly reduces death from left-sided colon cancer but not from right-sided colon cancer, according to a study published in the Annals of Internal Medicine.
The device will detect scarring from implants in the middle ear and the effects of diseases like Meniere's.
Its Express SD System is the first stent approved for use in renal artery disease.
Read the top nine issues that will change the face of U.S. healthcare system next year and perhaps make the system stronger.
Medel is a leader in portable nebulizers and has a strong market position in Europe and around the world. a branch of business related to the aerosoltherapy business, not the whole company as it is stated in your article. http://www.newscenter.philips.com/about/news/press/20081215_aerosol_acquisition.page We also found, in the article section "China Acquisition", another wrong statement, since Medel did not own any plant in China; Philips, in fact, acquired also one of our suppliers, Melhk ltd of Hong Kong, which did not belong to Medel. Please do not hesitate to contact me should you need any further information.
The company has also slashed profitability targets for 2010 due to the "speed and depth of recession."
Start-up Intelect Medical receives private equity funding for its implantable device aimed at stroke and traumatic brain injury patients.
The presence of zinc is crucial to the formation of infection-causing biofilms, University of Cincinnati researchers have found.
The Cleveland Clinic predicts medical innovations that will help revolutionize healthcare next year.
Transcranial Doppler Ultrasonography (TCD) and regular transfusions for children at high risk, reduced stroke to 1/10th of the incidence found before TCD was introduced.
Bard is now the only medical device maker offering both a stent and a stent graft for peripheral vascular disease.
An angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by 50 percent, researchers have found.
GE Capital, caught in the ongoing credit crunch, has gone from a cash cow to a liability for the company.
Cardinal Health will make disposable surgical kits for both companies while SRI will make reusables.
The company's well-established rental sales group and its imaging systems sales group work together to save providers money with their services.
The company will focus on core businesses including healthcare, Philips tells DOTmed News.
Now that healthcare company stocks are at record lows, J&J is expected to use its huge cash reserves to buy up more companies in the near future.
Citing midnight rules that would erode health and safety, nurses unveil website to "send Bush packing."
Cranberries contain antioxidants that are good for the heart and are protective against free radicals. As most of us know, they are also a first-line treatment for urinary tract infections. Less known is that cranberries are an effective treatment for periodontal disease because of their powerful anti-inflammatory effect, according to U.S. Cranberries.com, which markets the fruit.
The companies plan to integrate Medicsight's ColonCAD with Ziosoft's Ziostation and market the product next year, assuming it receives FDA clearance.
The fruit's high acid content helps inhibit bacterial growth along the urinary tract.
InHealth will give universities $1.7 million over the next two years to examine the cost-benefits of devices such as hearing aids and glucose pumps.
He sells and services Digirad's gamma cameras.
Next generation devices will be more secure as well as more sophisticated.